This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. U.S. regulators took action Wednesday that ...

The list price is $137.35 per vial. This story is from Kaiser Health News When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid ...

With 13% of the Michigan population living with diabetes, state legislators are embarking on a bold strategy to ensure ample production and affordability of insulin. Yet insulin prices are dropping ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients can ...

WASHINGTON (AP) - U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of a brand-name insulin at the drugstore. Doctors now have to specifically prescribe what’s ...

California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell ...

(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...

Lawmakers in Lansing began considering bills last week that would allow the state to partner with a private manufacturer to produce and distribute low-cost generic insulin. The state House Health ...

The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may ...

Insulin is an essential medicine that helps the body turn food into energy and regulate blood sugar levels for millions of people with diabetes nationwide. That makes access to insulin vital for ...

U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of brand-name insulin at the drugstore. Doctors now have to specifically prescribe what’s called a biosimilar ...

U.S. regulators took action Wednesday that will make it easier to get a cheaper, near-copy of a brand-name insulin at the drugstore. Doctors now have to specifically prescribe what’s called a ...